Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Trevena Inc (TRVN)

Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,402
  • Shares Outstanding, K 18,321
  • Annual Sales, $ -420 K
  • Annual Income, $ -53,670 K
  • 60-Month Beta 1.13
  • Price/Sales 1.52
  • Price/Cash Flow N/A
  • Price/Book 1.68
Trade TRVN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.80
  • Most Recent Earnings $-0.57 on 11/14/23
  • Latest Earnings Date 04/04/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 50.50%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,395.26% on 09/15/23
  • IV Low 0.00% on 03/28/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,352
  • Open Int (30-Day) 1,466

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.52
  • Number of Estimates 1
  • High Estimate -0.52
  • Low Estimate -0.52
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +28.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4068 +13.08%
on 03/22/24
0.6200 -25.81%
on 02/29/24
-0.1100 (-19.30%)
since 02/28/24
3-Month
0.4068 +13.08%
on 03/22/24
0.7693 -40.21%
on 01/10/24
-0.2489 (-35.11%)
since 12/28/23
52-Week
0.4068 +13.08%
on 03/22/24
3.2800 -85.98%
on 05/08/23
-0.2936 (-38.96%)
since 03/28/23

Most Recent Stories

More News
Trevena: Q3 Earnings Snapshot

Trevena: Q3 Earnings Snapshot

TRVN : 0.4600 (+0.31%)
Trevena: Q2 Earnings Snapshot

Trevena: Q2 Earnings Snapshot

TRVN : 0.4600 (+0.31%)
Trevena: Q1 Earnings Snapshot

Trevena: Q1 Earnings Snapshot

TRVN : 0.4600 (+0.31%)
Aadi Bioscience, Inc. (AADI) Reports Q1 Loss, Tops Revenue Estimates

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 1.72% and 8.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AADI : 2.34 (-1.27%)
TRVN : 0.4600 (+0.31%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

IMC.AX : 0.115 (+4.55%)
SILO : 1.9499 (+2.09%)
LLY : 777.96 (-0.03%)
ACOR : 13.21 (+10.92%)
TRVN : 0.4600 (+0.31%)
IMRN : 2.63 (-5.40%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

SILO : 1.9499 (+2.09%)
LLY : 777.96 (-0.03%)
ACOR : 13.21 (+10.92%)
TRVN : 0.4600 (+0.31%)
IMRN : 2.63 (-5.40%)
Trevena (NASDAQ: TRVN) Partner Receives Approval for OLINVYK in China

Trevena, Inc. (NASDAQ: TRVN) is engaged as a biopharmaceutical company, which is focused on the research, development and commercialization of

TRVN : 0.4600 (+0.31%)
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 0% and 5.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

KNSA : 19.73 (-1.30%)
TRVN : 0.4600 (+0.31%)
Trevena: Q4 Earnings Snapshot

Trevena: Q4 Earnings Snapshot

TRVN : 0.4600 (+0.31%)
Trevena (TRVN) Initiates Proof-of-Concept for Epilepsy Candidate

Trevena (TRVN) has initiated proof-of-concept study to evaluate TRV045 as a potential treatment for epilepsy and other CNS disorders.

TRVN : 0.4600 (+0.31%)
CRSP : 68.16 (-2.85%)
KALA : 7.97 (+1.53%)
ALLO : 4.47 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of...

See More

Key Turning Points

3rd Resistance Point 0.5233
2nd Resistance Point 0.5067
1st Resistance Point 0.4833
Last Price 0.4600
1st Support Level 0.4433
2nd Support Level 0.4267
3rd Support Level 0.4033

See More

52-Week High 3.2800
Fibonacci 61.8% 2.1824
Fibonacci 50% 1.8434
Fibonacci 38.2% 1.5044
Last Price 0.4600
52-Week Low 0.4068

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar